1174P RESUNET (GETNE-2016-01): A phase II study to evaluate the efficacy and safety of the rechallenge with sunitinib in G1/G2 pancreatic neuroendocrine tumours (pNET). A Spanish Task Force Group in neuroendocrine and endocrine tumours (GETNE) study
2020 ◽
Vol 31
◽
pp. S777-S778
E. Grande
◽
P. Espinosa-Olarte
◽
R. Serrano
◽
P. Jimenez
◽
T. Alonso
◽
...
E. Grande
◽
C. Lopez
◽
T. Alonso Gordoa
◽
M. Benavent
◽
J. Capdevila
◽
...
2015 ◽
Vol 51
◽
pp. S422-S423
R.P. Baum
◽
A.K. Kluge
◽
H.R. Kulkarni
◽
M. Sayeg
◽
U. Schorr-Neufing
◽
...
2011 ◽
Vol 104
(7)
◽
pp. 1067-1070
◽
L Medley
◽
A N Morel
◽
D Farrugia
◽
N Reed
◽
N Hayward
◽
...
2021 ◽
Vol 6
(5)
◽
pp. 100242
K. Klinghammer
◽
J. Fayette
◽
A. Kawecki
◽
A. Dietz
◽
P. Schafhausen
◽
...
Laura Cortesi
◽
Marta Venturelli
◽
Federica Caggia
◽
Luigi Marcheselli
◽
Annita Gozzi
◽
...
2018 ◽
Vol 105
◽
pp. 114-126
◽
Kenjiro Namikawa
◽
Yoshio Kiyohara
◽
Tatsuya Takenouchi
◽
Hisashi Uhara
◽
Hiroshi Uchi
◽
...
2010 ◽
Vol 123
(3)
◽
pp. 837-842
◽
Phuong K. Morrow
◽
Stephen Divers
◽
Louise Provencher
◽
Shiuh-Wen Luoh
◽
Teresa M. Petrella
◽
...
Close
Export Citation Format
Close
Share Document
Close